Pneumadin Inhibitors
Pneumadin inhibitors are a class of compounds designed to target and inhibit the activity of pneumadin, a peptide that is believed to play a role in regulating physiological processes such as water and salt balance in the body. Pneumadin is known for its interaction with certain receptors in the central nervous system and peripheral tissues, where it may influence fluid homeostasis and the modulation of certain autonomic functions. By inhibiting pneumadin, researchers aim to explore its downstream signaling pathways and effects on cellular processes. These inhibitors serve as valuable tools for understanding the biochemical role of pneumadin in various biological systems, allowing for a detailed analysis of its involvement in specific regulatory mechanisms.
The use of pneumadin inhibitors in research allows scientists to investigate how this peptide impacts homeostatic mechanisms at a molecular level, particularly within the cardiovascular and renal systems. By blocking pneumadin's activity, researchers can assess changes in cellular responses, including ion transport and neurohormonal regulation. Additionally, pneumadin inhibitors help clarify the relationship between pneumadin and other key signaling molecules involved in maintaining fluid and electrolyte balance. This can lead to a better understanding of how pneumadin fits into the broader network of signaling pathways responsible for regulating physiological stability. These studies may also provide insights into the peptide's broader role in various biological functions, making pneumadin inhibitors a critical tool for advancing research in the fields of biochemistry and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may downregulate Pneumadin expression by inhibiting histone deacetylase, leading to a more closed chromatin state and decreased gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent might reduce Pneumadin synthesis by incorporating into DNA and RNA, resulting in the inhibition of DNA methyltransferases, leading to hypomethylation and potentially to gene silencing. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could decrease Pneumadin levels by specifically inhibiting mTOR, a key kinase regulating cell growth and protein synthesis, which may lead to a reduction in peptide hormone production. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D might inhibit Pneumadin transcription by binding to DNA at the transcription initiation complex, preventing elongation of the RNA chain by RNA polymerase. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may inhibit Pneumadin expression by blocking the peptidyl transferase activity of the ribosome, halting protein elongation during translation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 could decrease Pneumadin mRNA levels by inhibiting DNA methyltransferases, which might result in the demethylation of gene promoter regions and suppression of gene activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 may reduce Pneumadin expression by competitively binding to the acetyl-lysine recognition pockets of BET bromodomains, displacing them from chromatin, leading to altered gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 could inhibit Pneumadin expression by blocking the PI3K/Akt signaling pathway, which is crucial for many cellular processes including transcription and translation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 might decrease Pneumadin levels by specifically inhibiting MEK1/2, which are upstream of the MAP kinase pathway, thereby potentially downregulating gene expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 may reduce the expression of Pneumadin by inhibiting the TGF-β receptor, which can lead to a downstream decrease in signaling pathways involved in cellular proliferation and differentiation. | ||||||